Reply to "A critical review of recombinant human bone morphogenetic protein-2 trials in spinal surgery: emerging safety concerns and lessons learned".

MLA

Dimar, John R., 2nd, et al. “Reply to ‘A Critical Review of Recombinant Human Bone Morphogenetic Protein-2 Trials in Spinal Surgery: Emerging Safety Concerns and Lessons Learned.’” The Spine Journal : Official Journal of the North American Spine Society, vol. 11, no. 11, Nov. 2011, pp. 1082–83. EBSCOhost, https://doi.org/10.1016/j.spinee.2011.09.029.

APA

Dimar, J. R., 2nd, Glassman, S. D., Burkus, J. K., Pryor, P. W., Hardacker, J. W., & Carreon, L. Y. (2011). Reply to “A critical review of recombinant human bone morphogenetic protein-2 trials in spinal surgery: emerging safety concerns and lessons learned.” The Spine Journal : Official Journal of the North American Spine Society, 11(11), 1082–1083. https://doi.org/10.1016/j.spinee.2011.09.029

Chicago

Dimar, John R, 2nd, Steven D Glassman, J Kenneth Burkus, Philip W Pryor, James W Hardacker, and Leah Y Carreon. 2011. “Reply to ‘A Critical Review of Recombinant Human Bone Morphogenetic Protein-2 Trials in Spinal Surgery: Emerging Safety Concerns and Lessons Learned.’” The Spine Journal : Official Journal of the North American Spine Society 11 (11): 1082–83. doi:10.1016/j.spinee.2011.09.029.